Table 2: Baseline characteristics of this population are summarized belo.: All data are from Bonfour et al. [11].

Gender Distribution Age (y)
Mean
[Range]
Classification Associated
Malignancy
ILD Therapy Prior
To IVIG
Time Until Initiation of Glucocorticoids (Mean/Range - Months)
3 M
24 F
52
(25-90)
ADM: 10 (37%)
hDM: 6 (22%)
pDM: 5 (19%)
CR-CDM: 6 (22%)
5 (19%) 3 (11%) TGC: 11 (41%)
TAC: 2(7%)
SGC: 11(41%)
HCQ: 14(52%)
MTX: 3(11%)
AZA: 1(4%)
34
(4-240)